Related Experiment Videos
Affinity maturation of recombinant antibodies using E. coli mutator cells
R A Irving1, A A Kortt, P J Hudson
1CSIRO Division of Biomolecular Engineering, Parkville, VIC, Australia.
Summary
This study developed a method to improve antibody binding affinity using engineered E. coli and phage display. This technique rapidly enhances antibody fragments (scFvs) for better antigen recognition.
Area of Science:
- Biotechnology
- Molecular Biology
- Immunology
Background:
- Phage libraries offer vast antibody repertoires exceeding mammalian immune responses.
- Selected antibodies often exhibit low binding affinity (KD > 10^-6 M), necessitating affinity maturation.
- Current methods lack efficient strategies to mimic somatic hypermutation for enhanced antibody affinity.
Purpose of the Study:
- To evaluate the efficacy of combining mutator E. coli strains with phage display for antibody gene mutation and affinity selection.
- To investigate antigen-driven affinity maturation of recombinant antibody genes.
- To enhance the binding affinity of selected immunoglobulins.
Main Methods:
- Selected unique human single-chain variable fragments (scFvs) from a naive phage library.
- Propagated scFv genes in mutD5 mutator E. coli cells to introduce point mutations (mutD5-FIT).
- Performed affinity selection of phage-displayed scFvs and assayed soluble scFvs using ELISA and BIAcore.
Main Results:
- In vivo mutation and affinity selection in E. coli mutD5-FIT significantly improved scFv binding activity.
- Single amino acid substitutions from point mutations led to up to tenfold increases in apparent binding affinity.
- Mutations occurred in complementarity-determining regions (CDRs) and adjacent framework regions, with one case showing a 1000-fold affinity increase.
Conclusions:
- Developed a rapid affinity maturation strategy for antibody fragments (scFvs and Fabs).
- The strategy effectively utilizes mutator E. coli strains and phage display technology.
- This method enhances antibody repertoires for improved antigen binding capabilities.